H&

Hambrecht & Quist Capital Management

North America, Massachusetts, United States, Boston

Description

Hambrecht & Quist Capital Management, LLC (HQCM), a registered investment adviser based in Boston, Massachusetts, is currently the

Investor Profile

Hambrecht & Quist Capital Management has made 44 investments, with 0 in the past 12 months and 5% as lead.

Stage Focus

  • Series C (30%)
  • Series B (23%)
  • Series Unknown (20%)
  • Series D (11%)
  • Series A (9%)
  • Private Equity (2%)
  • Series F (2%)
  • Debt Financing (2%)

Country Focus

  • United States (95%)
  • Israel (2%)
  • Canada (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Internet
  • Medical
  • E-commerce
  • Software
  • Medical Device
  • Pharmaceutical
  • Biopharma
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Hambrecht & Quist Capital Management frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 4
SoftBank
Asia, Chiba, Japan, Minato
Co-Investments: 3
CDP Capital Technology Ventures
North America, Quebec, Canada, Montréal
Co-Investments: 3
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 4
Pacific Rim Ventures
North America, California, United States, San Francisco
Co-Investments: 2
BioVeda Capital
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
U.S. Venture Partners
North America, California, United States, Menlo Park
Co-Investments: 3
Integra Ventures
North America, Washington, United States, Seattle
Co-Investments: 3
GeneChem
North America, Quebec, Canada, Montréal
Co-Investments: 3
Eucalyptus Ventures
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 3

Which angels does Hambrecht & Quist Capital Management often collaborate with?

Martha Stewart
North America, United States
Shared Deals: 1

What are some of recent deals done by Hambrecht & Quist Capital Management?

Veniti

Fremont, California, United States

Veniti develops medical devices for the treatment of chronic venous insufficiency disease.

BiotechnologyHealth CareMedicalMedical Device
Series BJun 4, 2013
Amount Raised: $9,720,856
Veniti

Fremont, California, United States

Veniti develops medical devices for the treatment of chronic venous insufficiency disease.

BiotechnologyHealth CareMedicalMedical Device
Series AMar 7, 2011
Amount Raised: $13,500,000
Tibion Bionic Technologies

Moffett Field, California, United States

AlterG, a medical device company, provides non-invasive actively-assisted mobility enhancement devices for the impaired people.

Health CareHealth DiagnosticsMedical Device
Series BMar 1, 2011
Amount Raised: $10,175,000
Euthymics Bioscience

Cambridge, Massachusetts, United States

Euthymics Bioscience, a neuroscience-focused biopharmaceutical company, develops medicines for central nervous system disorders.

Addiction TreatmentBiotechnologyLife SciencePharmaceutical
Series AJul 22, 2010
Amount Raised: $24,000,000
Eleme Medical

Merrimack, New Hampshire, United States

Eleme Medical is an aesthetics company developing proprietary technology for all areas of body shaping.

BiotechnologyHealth CarePharmaceutical
Series CJul 16, 2008
Amount Raised: $18,000,000
CardioKinetix

Menlo Park, California, United States

CardioKinetix is a medical device company offering the Parachutem, a catheter-based treatment for heart failure.

BiotechnologyHealth CareMedical Device
Series CJul 15, 2008
Amount Raised: $14,500,000
FlowCardia

Sunnyvale, California, United States

FlowCardia designs and develops catheter-based technologies for the treatment of totally occluded coronary and peripheral arteries.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series CAug 30, 2007
Amount Raised: $30,000,000
TargeGen

San Diego, California, United States

TargeGen, Inc., a vascular biology-focused biopharmaceutical company, discovers and develops small molecule kinase inhibitors that target.

BiopharmaBiotechnologyHealth Care
Series DJul 12, 2007
Amount Raised: $40,000,000
Athersys

Cleveland, Ohio, United States

Athersys is a biopharmaceutical company that discovers and develops therapeutic products to treat several disease indications.

BiopharmaBiotechnologyHealth CareLife ScienceMedical
Series UnknownJun 12, 2007
Amount Raised: $65,000,000
Xoft

San Jose, California, United States

Xoft develops electronic brachytherapy (eBx) systems for radiation oncology applications.

Advanced MaterialsElectronicsMedical DeviceOncology
Series DApr 5, 2007
Amount Raised: $33,200,000